Valuation: Pharmarise Holdings Corporation

Market Cap 5.82B 36.77M 32.84M 30.63M 27.83M 52.37M 3.56B 52.88M 368M 144M 1.81B 138M 135M P/E 2025
-15x
P/E 2026 52.6x
Enterprise Value 14.96B 94.52M 84.41M 78.74M 71.53M 135M 9.15B 136M 945M 370M 4.65B 355M 347M EV / Sales 2025
0.23x
EV / Sales 2026 0.22x
Free-Float
31.55%
Yield 2025
2.89%
Yield 2026 2.77%
09-17 Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months of Full Fiscal Year Ending May 31, 2027 CI
09-17 Pharmarise Holdings Corporation Reports Earnings Results for the First Quarter Ended August 31, 2026 CI
06-25 Pharmarise Holdings Corporation Proposes Dividend for the Fiscal Year Ended May 31, 2026, Payable on August 31, 2026; Provides Cash Dividend Guidance for the Fiscal Year Ending May 31, 2027 CI
06-25 Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year Ending May 31, 2027 CI
06-25 Pharmarise Holdings Corporation Reports Earnings Results for the Full Year Ended May 31, 2026 CI
03-19 Pharmarise Holdings Corporation Reports Earnings Results for the Nine Months Ended February 28, 2026 CI
01-29 Pharmarise Holdings Corporation agreed to acquire Sankou Medical Co.,Ltd. from Yoichi Sakazume and Kenji Sakazume for ¥1.5 billion. CI
25-06-24 Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2026 CI
25-06-24 Pharmarise Holdings Corporation Announces Dividend for the Fiscal Year Ending May 31, 2025, Payable on August 28, 2025 CI
25-06-24 Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year Ending May 31, 2026 CI
25-01-16 Pharmarise Holdings Swings to Loss in Six Months to November, 2024 MT
25-01-14 Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2025 CI
25-01-14 Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2025 CI
1 day-0.59%
1 week-0.20%
Current month-0.20%
1 month+0.20%
3 months+4.55%
6 months-3.07%
Current year-2.50%
1 week 505
Extreme 505
511
1 month 490
Extreme 490
514
Current year 471
Extreme 471
549
1 year 471
Extreme 471
554
3 years 456
Extreme 456
722
5 years 456
Extreme 456
835
10 years 456
Extreme 456
851
Manager TitleAgeSince
President 59 2018-07-31
Chief Administrative Officer 51 2025-02-28
Corporate Officer/Principal 50 2024-08-31
Director TitleAgeSince
Chairman 76 2016-08-24
Director/Board Member 77 1989-06-30
Director/Board Member 59 1997-01-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.59%-0.20%-4.53%-22.39% 37.02M
+0.06%-1.78%-45.39%-7.56% 14.36B
-0.56%+11.53%+12.09%-23.19% 7.37B
+2.25%+0.76%-9.55%+0.24% 5.98B
+0.88%+1.01%-16.88%-7.86% 6.07B
-0.35%-1.92%-56.84%-41.46% 5.81B
+0.94%+0.94%-4.54%-19.49% 4.22B
+0.51%+3.35%-23.60%-19.10% 3.17B
-0.66%-0.11%-24.63%-36.26% 3.17B
+0.88%+0.88%+11.34%-27.00% 3.09B
Average +0.34%+2.75%-16.25%-20.41% 5.33B
Weighted average by Cap. +0.37%+2.56%-22.33%-17.05%

Financials

2025 2026
Net sales 63.51B 401M 358M 334M 304M 571M 38.86B 577M 4.01B 1.57B 19.75B 1.51B 1.47B 69.51B 439M 392M 366M 332M 625M 42.54B 632M 4.39B 1.72B 21.61B 1.65B 1.61B
Net income -367M -2.32M -2.07M -1.93M -1.75M -3.3M -225M -3.33M -23.19M -9.07M -114M -8.71M -8.52M 114M 720K 643K 600K 545K 1.03M 69.76M 1.04M 7.2M 2.82M 35.45M 2.7M 2.65M
Net Debt 9.37B 59.19M 52.85M 49.31M 44.79M 84.29M 5.73B 85.11M 592M 232M 2.91B 222M 217M 9.14B 57.75M 51.57M 48.11M 43.7M 82.23M 5.59B 83.03M 578M 226M 2.84B 217M 212M
Projected Income Statement - Annual - Pharmarise Holdings Corporation
Logo Pharmarise Holdings Corporation
Pharmarise Holdings Corporation is primarily engaged in the dispensing pharmacy business. The Company operates through four business segments. The Dispensing Pharmacy segment involves operating pharmacies that dispense prescription medicines to patients based on prescriptions issued by medical institutions, functioning as insurance pharmacies under the Health Insurance Act. The Retail Sales segment involves selling non-prescription items such as over-the-counter (OTC) drugs, sanitary supplies, cosmetics, and daily necessities through outlets such as drugstores and convenience stores. The Medical Records Storage and Management segment involves storing and managing medical records such as patient charts created during medical examinations in warehouses on behalf of medical institutions. The Medical Mall Management segment involves the operation of a medical mall located within the JR Tower Office Plaza Sapporo at JR Sapporo Station.
Employees
2,031
Date Price Change Volume
26-10-08 JP¥506.00 -0.59% 4,600
26-10-07 JP¥509.00 +0.20% 1,200
26-10-06 JP¥508.00 -0.39% 5,600
26-10-05 JP¥510.00 +0.20% 4,400
26-10-02 JP¥509.00 +0.20% 4,000

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Pharmarise Holdings Corporation
  1. Stock Market
  2. Stocks
  3. 2796 Stock